Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. STAT is running a promo this week — you can get 40% off an annual subscription with the discount code STAT40. Learn more here.
Bernie amps up the pressure on Novo
After Senate health committee chair Bernie Sanders launched an investigation into Novo Nordisk’s pricing of Ozempic and Wegovy in April, he’s now called a vote to subpoena the chief of the company’s U.S. division.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect